Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 22 (11), 2769-88

Non-pharmacological Management of Osteoporosis: A Consensus of the Belgian Bone Club


Non-pharmacological Management of Osteoporosis: A Consensus of the Belgian Bone Club

J-J Body et al. Osteoporos Int.


This consensus article reviews the various aspects of the non-pharmacological management of osteoporosis, including the effects of nutriments, physical exercise, lifestyle, fall prevention, and hip protectors. Vertebroplasty is also briefly reviewed. Non-pharmacological management of osteoporosis is a broad concept. It must be viewed as an essential part of the prevention of fractures from childhood through adulthood and the old age. The topic also includes surgical procedures for the treatment of peripheral and vertebral fractures and the post-fracture rehabilitation. The present document is the result of a consensus, based on a systematic review and a critical appraisal of the literature. Diets deficient in calcium, proteins or vitamin D impair skeletal integrity. The effect of other nutriments is less clear, although an excessive consumption of sodium, caffeine, or fibres exerts negative effects on calcium balance. The deleterious effects of tobacco, excessive alcohol consumption and a low BMI are well accepted. Physical activity is of primary importance to reach optimal peak bone mass but, if numerous studies have shown the beneficial effects of various types of exercise on bone mass, fracture data as an endpoint are scanty. Fall prevention strategies are especially efficient in the community setting, but less evidence is available about their effectiveness in preventing fall-related injuries and fractures. The efficacy of hip protectors remains controversial. This is also true for vertebroplasty and kyphoplasty. Several randomized controlled studies had reported a short-term advantage of vertebroplasty over medical treatment for pain relief, but these findings have been questioned by recent sham-controlled randomized clinical studies.

Similar articles

See all similar articles

Cited by 28 PubMed Central articles

See all "Cited by" articles


    1. Melton LJ, 3rd, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res. 1998;13:1915–1923. doi: 10.1359/jbmr.1998.13.12.1915. - DOI - PubMed
    1. Autier P, Haentjens P, Bentin J, Baillon JM, Grivegnee AR, Closon MC, Boonen S. Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group. Osteoporos Int. 2000;11:373–380. doi: 10.1007/s001980070102. - DOI - PubMed
    1. Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int. 2010;21:1657–1680. doi: 10.1007/s00198-010-1223-4. - DOI - PMC - PubMed
    1. Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res. 1999;14:633–643. doi: 10.1359/jbmr.1999.14.4.633. - DOI - PubMed
    1. Drake AJ, 3rd, Armstrong DW, 3rd, Shakir KM. Bone mineral density and total body bone mineral content in 18- to 22-year-old women. Bone. 2004;34:1037–1043. doi: 10.1016/j.bone.2004.01.021. - DOI - PubMed

MeSH terms